Drug Delivery System
Online ISSN : 1881-2732
Print ISSN : 0913-5006
ISSN-L : 0913-5006
[Feature articles] “DDS for α-radiation therapy” Editor:Shino Manabe
Production of radioisotopes for targeted radionuclide therapy at RIKEN
Hiromitsu Haba
Author information
JOURNAL FREE ACCESS

2020 Volume 35 Issue 2 Pages 114-120

Details
Abstract
We are developing production technologies of radioisotopes(RIs)for application studies using heavy-ion accelerators at RIKEN RI Beam Factory (RIBF). More than 100 RIs produced at the AVF cyclotron, RIKEN Linear Accelerator, and RIKEN Ring Cyclotron have been used in research fields of physics, chemistry, biology, engineering, medicine, pharmaceutical and environmental sciences. In this article, production technologies of cupper-67 and astatin-211 for future targeted radionuclide therapy are presented. Among RIKEN RIs, purified RIs such as zinc-65 and cadmium-109 are delivered to universities and institutes through Japan Radioisotope Association. Short-lived RIs are also distributed to researchers through the platform for short-lived RI distribution supported by KAKENHI.
Content from these authors
© 2020 The Japan Society of Drug Delivery System
Previous article Next article
feedback
Top